GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zhongyuan Union Cell & Gene Engineering Corp Ltd (SHSE:600645) » Definitions » Market Cap

Zhongyuan Union Cell & Gene Engineering (SHSE:600645) Market Cap : ¥10,505 Mil (As of Apr. 23, 2025)


View and export this data going back to 1993. Start your Free Trial

What is Zhongyuan Union Cell & Gene Engineering Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Zhongyuan Union Cell & Gene Engineering's share price for the quarter that ended in Sep. 2024 was ¥21.89. Zhongyuan Union Cell & Gene Engineering's Shares Outstanding (EOP) for the quarter that ended in Sep. 2024 was 468 Mil. Therefore, Zhongyuan Union Cell & Gene Engineering's market cap for the quarter that ended in Sep. 2024 was ¥10,243 Mil.

Zhongyuan Union Cell & Gene Engineering's quarterly market cap declined from Mar. 2024 (¥7,674 Mil) to Jun. 2024 (¥7,534 Mil) but then increased from Jun. 2024 (¥7,534 Mil) to Sep. 2024 (¥10,243 Mil).

Zhongyuan Union Cell & Gene Engineering's annual market cap declined from Dec. 2021 (¥11,811 Mil) to Dec. 2022 (¥7,960 Mil) but then increased from Dec. 2022 (¥7,960 Mil) to Dec. 2023 (¥9,485 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Zhongyuan Union Cell & Gene Engineering's Enterprise Value for Today is ¥9,201 Mil.


Zhongyuan Union Cell & Gene Engineering Market Cap Historical Data

The historical data trend for Zhongyuan Union Cell & Gene Engineering's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhongyuan Union Cell & Gene Engineering Market Cap Chart

Zhongyuan Union Cell & Gene Engineering Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7,922.73 9,176.48 11,811.03 7,959.81 9,485.33

Zhongyuan Union Cell & Gene Engineering Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8,507.31 9,485.33 7,674.36 7,533.98 10,243.40

Competitive Comparison of Zhongyuan Union Cell & Gene Engineering's Market Cap

For the Biotechnology subindustry, Zhongyuan Union Cell & Gene Engineering's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhongyuan Union Cell & Gene Engineering's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zhongyuan Union Cell & Gene Engineering's Market Cap distribution charts can be found below:

* The bar in red indicates where Zhongyuan Union Cell & Gene Engineering's Market Cap falls into.


;
;

Zhongyuan Union Cell & Gene Engineering Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Zhongyuan Union Cell & Gene Engineering's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=¥20.27*467.949
=¥9,485

Zhongyuan Union Cell & Gene Engineering's Market Cap for the quarter that ended in Sep. 2024 is calculated as

Market Cap (Q: Sep. 2024 )=Share Price (Q: Sep. 2024 )*Shares Outstanding (EOP) (Q: Sep. 2024 )
=¥21.89*467.949
=¥10,243

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zhongyuan Union Cell & Gene Engineering  (SHSE:600645) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Zhongyuan Union Cell & Gene Engineering Market Cap Related Terms

Thank you for viewing the detailed overview of Zhongyuan Union Cell & Gene Engineering's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhongyuan Union Cell & Gene Engineering Business Description

Traded in Other Exchanges
N/A
Address
45 East of Tianjin Airport Economic Zone nine, Tianjin, CHN, 300304
Zhongyuan Union Cell & Gene Engineering Corp Ltd is engaged in stem cell technology research, as well as detection and storage sources of stem cells in China. The company insists on the core strategy upon dual-core development of 'cell + gene' with the major businesses covering various cell storage businesses of newborns and adults; the preparation and storage of cord blood hematopoietic stem cells, umbilical cord mesenchymal stem cells, placental pluripotent stem cells, adipose-derived stem cells and immune cells; genetic testing services relating to children's genes.
Executives
Li De Fu Director
Wang Xue Jun senior management
Wang Yong Director
Li Hai Bin Director
He Wei senior management
Li Qiang senior management
Wu Ming Yuan Director
Wang Hui Director
Huang Jia Xue senior management
Cao Hai Feng Director
Han Yue E Director
Liu Yong Jun senior management
Cui Jing Xue Supervisors
Yang Guang Xing senior management
Meng Zhi Hong senior management

Zhongyuan Union Cell & Gene Engineering Headlines

No Headlines